Shanghai MicuRx Pharmaceutical Co., Ltd.

SHSE:688373 Stock Report

Market Cap: CN¥3.3b

Shanghai MicuRx Pharmaceutical Past Earnings Performance

Past criteria checks 0/6

Shanghai MicuRx Pharmaceutical's earnings have been declining at an average annual rate of -29.4%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 53.1% per year.

Key information

-29.4%

Earnings growth rate

-11.9%

EPS growth rate

Biotechs Industry Growth11.3%
Revenue growth rate53.1%
Return on equity-82.4%
Net Margin-389.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Shanghai MicuRx Pharmaceutical Co., Ltd.'s (SHSE:688373) 26% Share Price Surge Not Quite Adding Up

Apr 07
Shanghai MicuRx Pharmaceutical Co., Ltd.'s (SHSE:688373) 26% Share Price Surge Not Quite Adding Up

Revenue & Expenses Breakdown

How Shanghai MicuRx Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688373 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24120-468182386
30 Jun 24109-497178415
31 Mar 24107-467184386
31 Dec 2391-421169345
30 Sep 2382-291159238
30 Jun 2370-238161181
31 Mar 2355-225149161
31 Dec 2248-220146150
30 Sep 2237-275144180
30 Jun 2228-247134160
31 Mar 2218-242134159
31 Dec 218-226124152
31 Dec 200-864253
31 Dec 190-1153394
31 Dec 181-15026141

Quality Earnings: 688373 is currently unprofitable.

Growing Profit Margin: 688373 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688373 is unprofitable, and losses have increased over the past 5 years at a rate of 29.4% per year.

Accelerating Growth: Unable to compare 688373's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 688373 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (0.08%).


Return on Equity

High ROE: 688373 has a negative Return on Equity (-82.44%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies